Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Resonate BlendsKOAN Receivables Turnover is 15.13 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 947 Drug Manufacturers companies, Resonate Blends ranks better than 98.42% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Resonate Blends's Revenue for the
three
months ended in Mar. 2026 was $0.24 Mil. Resonate Blends's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.02 Mil.
Hence, Resonate Blends's Receivables Turnover for the
three
months ended in Mar. 2026 was 15.13.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Resonate Blends Receivables Turnover Related Terms
Resonate Blends Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Resonate Blends's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KOAN vs OWPC, PTPI, CBSTQ: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonate Blends Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Resonate Blends's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonate Blends (KOAN) has a Receivables Turnover of 15.13 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Resonate Blends and its competitors. According to the industry distribution chart, Resonate Blends ranks #15 out of 947 companies in the Drug Manufacturers industry, placing it in the top 1.6%.
Is Resonate Blends' Receivables Turnover too high?
Resonate Blends' current Receivables Turnover is 15.13. The Drug Manufacturers industry median Receivables Turnover is 5.08. Resonate Blends' value of 15.13 is 197.8% above this industry median. Based on the distribution chart, Resonate Blends ranks #15 out of 947 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Resonate Blends' Receivables Turnover compare to OWPC and PTPI?
According to the Drug Manufacturers industry distribution chart, Resonate Blends ranks #15 out of 947 companies for Receivables Turnover. This places Resonate Blends in the top 2% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.08. Resonate Blends' value of 15.13 is 197.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.08, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonate Blends's current Receivables Turnover of 15.13 is 197.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Resonate Blends and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonate Blends's current Receivables Turnover is 15.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonate Blends stock overvalued right now?
Resonate Blends (KOAN) has a current Receivables Turnover of 15.13. The current Receivables Turnover is 15.13 and 197.8% above the Drug Manufacturers industry median of 5.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Resonate Blends (KOAN), the current Receivables Turnover is 15.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonate Blends Inc is engaged in the discovery, development, and marketing of nutritionally designed regenerative medicine and wellness products. The company focuses on natural stem cell mobilizing agents, diet aids, and bioactive formulations intended to enhance human performance and support health and wellness for consumer and professional markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KOAN has been successfully added to your 
